The estimated Net Worth of Eric Schoen is at least $834 millier dollars as of 17 April 2024. Mr Schoen owns over 1,500 units of Cassava Sciences Inc stock worth over $582,129 and over the last 13 years he sold SAVA stock worth over $0. In addition, he makes $251,932 as Chief Financial Officer at Cassava Sciences Inc.
Sign up
Mr Schoen SAVA stock SEC Form 4 insiders trading
Mr has made over 8 trades of the Cassava Sciences Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 1,500 units of SAVA stock worth $33,000 on 17 April 2024.
The largest trade he's ever made was buying 19,525 units of Cassava Sciences Inc stock on 15 November 2011 worth over $23,040. On average, Mr trades about 3,114 units every 239 days since 2011. As of 17 April 2024 he still owns at least 21,300 units of Cassava Sciences Inc stock.
You can see the complete history of Mr Schoen stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Eric J. Schoen biography
Eric J. Schoen is the Chief Financial Officer at Cassava Sciences Inc.
What is the salary of Mr Schoen?
As the Chief Financial Officer of Cassava Sciences Inc, the total compensation of Mr Schoen at Cassava Sciences Inc is $251,932. There are 4 executives at Cassava Sciences Inc getting paid more, with Remi Barbier having the highest compensation of $1,073,230.
How old is Mr Schoen?
Mr Schoen is 53, he's been the Chief Financial Officer of Cassava Sciences Inc since . There are 8 older and 1 younger executives at Cassava Sciences Inc. The oldest executive at Cassava Sciences Inc is Sanford Robertson, 88, who is the Independent Director.
What's Mr Schoen's mailing address?
Eric's mailing address filed with the SEC is 6801 N CAPITAL OF TEXAS HWY, BLDG 1, SUITE 300, AUSTIN, TX, 78731.
Insiders trading at Cassava Sciences Inc
Over the last 6 years, insiders at Cassava Sciences Inc have traded over $0 worth of Cassava Sciences Inc stock and bought 1,178,376 units worth $9,853,781 . The most active insiders traders include Sanford Robertson, Richard Barry et Patrick J Md Phd Scannon. On average, Cassava Sciences Inc executives and independent directors trade stock every 45 days with the average trade being worth of $1,235,207. The most recent stock trade was executed by Sanford Robertson on 26 April 2024, trading 69,000 units of SAVA stock currently worth $1,518,000.
What does Cassava Sciences Inc do?
refer to descriptions included in the company's filings with the securities and exchange commission for more information about the company. the company does not intend to update and does not take responsibility for any information published on linkedin.
What does Cassava Sciences Inc's logo look like?
Complete history of Mr Schoen stock trades at Vermillion et Cassava Sciences Inc
Cassava Sciences Inc executives and stock owners
Cassava Sciences Inc executives and other stock owners filed with the SEC include:
-
Remi Barbier,
Chairman of the Board, President, Chief Executive Officer -
Remi Barbier,
Founder, Chairman, Pres & CEO -
Nadav Friedmann,
Chief Medical and Operating Officer, Director -
Dr. Nadav Friedmann,
Chief Medical Officer & Director -
Eric J. Schoen,
Chief Financial Officer -
Eric Schoen,
Chief Financial Officer -
Sanford Robertson,
Independent Director -
Robert Gussin,
Independent Director -
Patrick Scannon,
Independent Director -
Michael O' Donnell,
Independent Director -
Dr. James W. Kupiec M.D.,
Chief Clinical Devel. Officer -
Dr. Lindsay H. Burns Ph.D.,
Sr. VP of Neuroscience -
Dr. Michael Marsman,
Sr. VP of Regulatory Affairs -
Michael Zamloot,
Sr. VP of Technical Operations -
Dr. George Thornton,
Sr. VP of Technology -
Saira Ramasastry,
Director -
Pierre Gravier,
Director -
Claude Nicaise,
Director -
Robert Christopher Cook,
SVP & General Counsel -
Richard Barry,
Director -
James William Kupiec,
Chief Medical Officer -
Robert Eugene Jr Anderson,
Director